Strongbridge Bio Ord (SBBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SBBP | AMGN | VRTX | REGN | GILD |
| Company | Strongbridge Bio Ord | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.96 | 311.49 | 477.52 | 1,042.28 | 68.24 |
| High | 2.06 | 312.54 | 477.52 | 1,047.25 | 68.33 |
| Low | 1.95 | 306.11 | 466.01 | 1,011.67 | 66.66 |
| Last | 2.00 | 307.18 | 469.27 | 1,022.41 | 67.24 |
| Change | +0.03 | -3.59 | -4.51 | -22.25 | -1.16 |
| % Change | +1.52% | -1.16% | -0.95% | -2.13% | -1.70% |
| Volume | 684,600 | 272,286 | 278,283 | 112,999 | 1,232,947 |
| 20-Day Average Volume | 234,660 | 2,350,560 | 1,238,677 | 462,194 | 9,054,817 |
| Previous Close | 1.97 | 310.77 | 473.78 | 1,044.66 | 68.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.10 | 307.77 | 475.63 | 1,036.59 | 66.65 |
| 20-Day Raw Stochastic | 13.51% | 41.69% | 31.80% | 43.36% | 42.02% |
| 20-Day Relative Strength | 42.28% | 53.32% | 58.05% | 55.49% | 48.92% |
| Weighted Alpha | -28.48 | +34.76 | +40.41 | +44.37 | -13.55 |
| Today's Opinion | 100% Sell | 100% Buy | 88% Buy | 80% Buy | 40% Sell |
| Previous Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | 88% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.91% since 09/28/21 | -1.49% since 06/26/24 | -0.72% since 06/26/24 | -5.01% since 06/26/24 | -3.80% since 06/26/24 |
| Low | 1.95 on 10/05/21 | 307.64 on 07/02/24 | 467.41 on 07/02/24 | 1,014.37 on 07/03/24 | 66.66 on 07/03/24 |
| High | 2.11 on 09/29/21 | 319.00 on 07/01/24 | 478.96 on 07/01/24 | 1,073.05 on 06/27/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | -10.71% since 09/03/21 | +0.24% since 06/03/24 | +0.09% since 06/03/24 | +2.64% since 06/03/24 | +5.12% since 06/03/24 |
| Low | 1.95 on 10/05/21 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 986.64 on 06/04/24 | 62.69 on 06/18/24 |
| High | 2.32 on 09/10/21 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -35.06% since 07/02/21 | +12.29% since 04/03/24 | +15.12% since 04/03/24 | +6.80% since 04/03/24 | -5.95% since 04/03/24 |
| Low | 1.85 on 08/16/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 3.19 on 07/06/21 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | -28.06% since 04/05/21 | +2.48% since 01/03/24 | +14.58% since 01/03/24 | +10.68% since 01/03/24 | -20.13% since 01/03/24 |
| Low | 1.85 on 08/16/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 3.19 on 07/06/21 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 135,658 | 166,707,904 | 122,260,352 | 115,106,896 | 85,216,352 |
| Shares Outstanding, K | 67,829 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 30,730,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -45,080,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 10,040,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -13,240,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.59 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/05/21 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 11/04/21 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.69 | 31.29 | 28.48 | 17.03 |